Nutra Pharma Corp

CIK 1119643 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Nutra Pharma Corp.

Recent SEC filings

FiledFormAccession number
Sep 2, 20268-K0001493152-26-041208
Sep 1, 202630001493152-26-041005
Sep 1, 2026SCHEDULE 13D0001493152-26-041007
Sep 1, 202640001493152-26-041002
Aug 19, 202610-Q0001493152-26-039166
Aug 14, 2026NT 10-Q0001493152-26-038022
May 29, 202610-Q0001493152-26-026420
May 20, 202610-K0001493152-26-024641
Apr 6, 202610-Q0001493152-26-015334
Mar 25, 202610-Q0001493152-26-012625
Mar 11, 202610-Q0001493152-26-009667
Feb 17, 202610-K0001493152-26-007044
Jan 2, 202610-Q0001493152-26-000067
Dec 23, 202510-Q0001493152-25-028946
Dec 17, 202510-Q0001493152-25-028202
Nov 24, 202510-K0001493152-25-024800
Oct 28, 202510-Q0001493152-25-019875
Oct 23, 202510-Q0001493152-25-019037
Oct 16, 202510-Q0001493152-25-018328
Sep 3, 202510-K0001641172-25-026446
Sep 3, 20258-K0001641172-25-026384
Mar 22, 20248-K0001493152-24-010998
Nov 21, 202210-Q0001493152-22-033171
Nov 15, 2022NT 10-Q0001493152-22-032495
Aug 22, 202210-Q0001493152-22-023751